
NASDAQHealthcareMedical - Devices
最新資料
US$13.44
+US$0.03 · +0.22%
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
前收盤價
US$13.44
+US$0.03 · +0.22%
盤中時間採用ET。市場資料可能有所延遲。
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
日內區間
目前US$13.44
52週區間
目前US$13.44
盤中時間採用ET。市場資料可能有所延遲。
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
日內區間
目前US$13.44
52週區間
目前US$13.44
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 16.35億 USD | 16.11億 USD | 15.42億 USD | 15.58億 USD | 15.42億 USD |
| 銷貨成本 | 7.9億 USD | 7.28億 USD | 6.57億 USD | 5.87億 USD | 5.98億 USD |
| 毛利 | 8.45億 USD | 8.82億 USD | 8.85億 USD | 9.7億 USD | 9.45億 USD |
| 研究與開發 | 9897.1萬 USD | 1.15億 USD | 1.04億 USD | 1.01億 USD | 9305.1萬 USD |
| 銷售、一般及管理費用 | 7億 USD | 7.17億 USD | 6.57億 USD | 6.16億 USD | 6.37億 USD |
| 營業費用 | 7.77億 USD | 8.54億 USD | 7.73億 USD | 7.31億 USD | 7.47億 USD |
| 利息收入 | 1847.4萬 USD | 2004萬 USD | 1720.2萬 USD | 1191.7萬 USD | 673.7萬 USD |
| 利息支出 | 8625.5萬 USD | 7063.2萬 USD | 5137.7萬 USD | 4959.4萬 USD | 5039.5萬 USD |
| 折舊和攤銷 | 1.52億 USD | 1.41億 USD | 1.24億 USD | 1.18億 USD | 1.2億 USD |
| 營業利益 | 6831.8萬 USD | 2841.1萬 USD | 1.12億 USD | 2.39億 USD | 1.97億 USD |
| 淨利 | −5.16億 USD | −694.4萬 USD | 6774.1萬 USD | 1.81億 USD | 1.69億 USD |
公司資料更新於 2026年10月11日。
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR5292.63萬0.05%1031.91億 USD0.06%US$137.55+0.17%
Vanguard Morningstar Total Stock Market ETFVTI3567.24萬0.00%2.3兆 USD0.03%US$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB2571.18萬0.01%1853億 USD0.03%US$289.48+0.64%
iShares Russell 2000 ETFIWM2409.24萬0.03%787.4億 USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap Value ETFVBR1634.93萬0.02%682億 USD0.05%US$234.43+0.22%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1440.92萬0.05%268.09億 USD0.33%US$37.95-0.39%
Vanguard Extended Market ETFVXF1317.01萬0.01%954億 USD0.05%US$235+0.80%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM815.41萬0.05%158.4億 USD0.03%US$53.45+0.17%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。